Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine

By Sato H.   Yamamura J.-i.   Kageyama S.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine

By Vafai A.  

Vaccine, Vol. 13, Iss. 14, 1995-10 ,pp. : 1336-1338

Elsevier

Access to resources Recommend Favorite

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

By Trannoy E.   Berger R.   Hollander G.   Bailleux F.   Heimendinger P.   Vuillier D.   Creusvaux H.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1700-1706

Elsevier

Access to resources Recommend Favorite

Seroprevalence of varicella-zoster virus in the German population

By Wutzler P.   Farber I.   Wagenpfeil S.   Bisanz H.   Tischer A.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 121-124

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite